✨ Health Notices
20 SEPTEMBER 2007 NEW ZEALAND GAZETTE, No. 102
2765
● The medicine may only be prescribed by:
– registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified
by the Medical Council of New Zealand as competent in the scope of practice of psychiatry; and
– medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the
kind referred to above.
● Persons prescribing the medicine must comply with appropriate local treatment guidelines.
● The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
● Sale or marketing of this medicine may only occur if:
– the sponsor has an appropriate blood monitoring and patient record database in place; and
– the sponsor creates or participates in a central “red flag” database identifying patients who have previously been
prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated.
Note: This consent is valid for two years from 19 October 2006.
Product: Zopine
Active Ingredient: Clozapine 25mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Alphapharm Pty Limited, Carole Park, Brisbane, Queensland, Australia
Note: This consent is given subject to the following conditions:
● The medicine may only be prescribed by:
– registered medical practitioners as defined in the Health Practitioners Competence Assurance Act 2003 who are certified
by the Medical Council of New Zealand as competent in the scope of practice of psychiatry; and
– medical practitioners employed as registrars in the branch of psychiatry who are under the supervision of persons of the
kind referred to above.
● Persons prescribing the medicine must comply with appropriate local treatment guidelines.
● The medicine must be dispensed in accordance with appropriate local dispensing guidelines.
● Sale or marketing of this medicine may only occur if:
– the sponsor has an appropriate blood monitoring and patient record database in place; and
– the sponsor creates or participates in a central “red flag” database identifying patients who have previously been
prescribed clozapine and who developed adverse drug reactions, which mean further use is contraindicated.
Note: This consent is valid for two years from 19 October 2006.
Dated this 14th day of September 2007.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation
given by the Minister of Health on 6 July 2001).
go6516
Mental Health (Compulsory Assessment and Treatment) Act 1992
Mental Health (Compulsory Assessment and Treatment) Act Notice 2007—Appointment of Director of Area Mental Health Services
Pursuant to section 92 of the Mental Health (Compulsory Assessment and Treatment) Act 1992, I, Stephen Bruce McKernan, Director-General of Health, give the following notice.
Notice
-
This notice shall be read together with the Mental Health (Compulsory Assessment and Treatment) Act Notice 2000—Appointment of Directors of Area Mental Health Services (“the principal notice”)*.
-
The Schedule to the principal notice is amended in respect of
“Area 12—West Coast”
by omitting the name and title
“Abraham Nicolaas van der Walt, medical practitioner, of Greymouth”
and substituting the name and title
“Philip Brinded, consultant psychiatrist, of Christchurch”.
Dated at Wellington this 12th day of September 2007.
STEPHEN BRUCE MCKERNAN, Director-General of Health.
New Zealand Gazette, 31 August 2000, No. 117, page 2963
go6418
Misuse of Drugs Act 1975
Prohibition of the Prescribing of Class B Controlled Drugs
Pursuant to section 23(1)(a) of the Misuse of Drugs Act 1975, I, Pete Hodgson, Minister of Health, on the recommendation of the Medical Council of New Zealand, hereby prohibit the prescribing of Class B controlled drugs by
Dr Fergus Bruce Aitcheson, medical practitioner of Gisborne.
Dated at Wellington this 8th day of September 2007.
HON. PETE HODGSON, Minister of Health.
go6408
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 102
Gazette.govt.nz —
NZ Gazette 2007, No 102
✨ LLM interpretation of page content
🏥 Provisional Consent for Zopine (Clozapine 25mg Tablet)
🏥 Health & Social Welfare14 September 2007
Medicines, Zopine, Clozapine, Provisional Consent, Distribution, Prescription Guidelines
- John Hazeldine, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Appointment of Director of Area Mental Health Services
🏥 Health & Social Welfare12 September 2007
Mental Health, Appointment, Director of Area Mental Health Services, West Coast
- Abraham Nicolaas van der Walt (medical practitioner), Removed as Director of Area Mental Health Services
- Philip Brinded (consultant psychiatrist), Appointed as Director of Area Mental Health Services
- Stephen Bruce McKernan, Director-General of Health
🏥 Prohibition of the Prescribing of Class B Controlled Drugs
🏥 Health & Social Welfare8 September 2007
Drugs, Prescription, Prohibition, Class B Controlled Drugs
- Fergus Bruce Aitcheson (Doctor), Prohibited from prescribing Class B controlled drugs
- Hon. Pete Hodgson, Minister of Health